Global and United States Insulin Like Growth Factor I In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Insulin Like Growth Factor I industry.
Major Companies
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Regulaxis SAS
...
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Insulin Like Growth Factor I Market, byGB-845
Insulin Like Growth Factor I Market, bysigitumab
Insulin Like Growth Factor I Market, by-6
Insulin Like Growth Factor I Market, by610.27
Insulin Like Growth Factor I Market, by630
Insulin Like Growth Factor I Market, by Key Consumers
Alzheimer's Disease
Breast Cancer
Huntington Disease
Muscular Dystrophy
Others
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Insulin Like Growth Factor I industry.
Major Companies
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Regulaxis SAS
...
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Insulin Like Growth Factor I Market, byGB-845
Insulin Like Growth Factor I Market, bysigitumab
Insulin Like Growth Factor I Market, by-6
Insulin Like Growth Factor I Market, by610.27
Insulin Like Growth Factor I Market, by630
Insulin Like Growth Factor I Market, by Key Consumers
Alzheimer's Disease
Breast Cancer
Huntington Disease
Muscular Dystrophy
Others
CHAPTER ONE GLOBAL INSULIN LIKE GROWTH FACTOR I MARKET OVERVIEW
1.1 Global Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
1.2 Insulin Like Growth Factor I, by B-845 2012-2017
1.2.1 Global Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
1.2.2 Global Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
1.2.3 Global Insulin Like Growth Factor I Price by B-845 2012-2017
1.2.4
1.2.5
1.3 Insulin Like Growth Factor I, by igitumab 2012-2017
1.3.1 Global Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
1.3.2 Global Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
1.3.3 Global Insulin Like Growth Factor I Price by igitumab 2012-2017
1.3.4
1.3.5
1.4 Insulin Like Growth Factor I, by 6 2012-2017
1.4.1 Global Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
1.4.2 Global Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
1.4.3 Global Insulin Like Growth Factor I Price by 6 2012-2017
1.4.4
1.4.5
1.5 Insulin Like Growth Factor I, by 10.27 2012-2017
1.5.1 Global Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
1.5.2 Global Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
1.5.3 Global Insulin Like Growth Factor I Price by 10.27 2012-2017
1.5.4
1.5.5
1.6 Insulin Like Growth Factor I, by 30 2012-2017
1.6.1 Global Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
1.6.2 Global Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
1.6.3 Global Insulin Like Growth Factor I Price by 30 2012-2017
1.6.4
1.6.5
CHAPTER TWO UNITED STATES INSULIN LIKE GROWTH FACTOR I MARKET OVERVIEW
2.1 United States Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
2.2 Insulin Like Growth Factor I, by B-845 2012-2017
2.2.1 United States Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
2.2.2 United States Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
2.2.3 United States Insulin Like Growth Factor I Price by B-845 2012-2017
2.2.4
2.2.5
2.3 Insulin Like Growth Factor I, by igitumab 2012-2017
2.3.1 United States Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
2.3.2 United States Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
2.3.3 United States Insulin Like Growth Factor I Price by igitumab 2012-2017
2.3.4
2.3.5
2.4 Insulin Like Growth Factor I, by 6 2012-2017
2.4.1 United States Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
2.4.2 United States Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
2.4.3 United States Insulin Like Growth Factor I Price by 6 2012-2017
2.4.4
2.4.5
2.5 Insulin Like Growth Factor I, by 10.27 2012-2017
2.5.1 United States Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
2.5.2 United States Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
2.5.3 United States Insulin Like Growth Factor I Price by 10.27 2012-2017
2.5.4
2.5.5
2.6 Insulin Like Growth Factor I, by 30 2012-2017
2.6.1 United States Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
2.6.2 United States Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
2.6.3 United States Insulin Like Growth Factor I Price by 30 2012-2017
2.6.4
2.6.5
CHAPTER THREE INSULIN LIKE GROWTH FACTOR I BY REGIONS 2012-2017
3.1 Global Insulin Like Growth Factor I Sales Market Share by Regions 2012-2017
3.2 Global Insulin Like Growth Factor I Revenue Market Share by Regions 2012-2017
3.3 Global Insulin Like Growth Factor I Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL INSULIN LIKE GROWTH FACTOR I BY COMPANIES 2012-2017
4.1 Global Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
4.2 Global Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
4.3 Global Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
4.4 Global Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES INSULIN LIKE GROWTH FACTOR I BY COMPANIES 2012-2017
5.1 United States Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
5.2 United States Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
5.3 United States Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
5.4 United States Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL INSULIN LIKE GROWTH FACTOR I BY CONSUMER 2012-2017
6.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
6.2 Alzheimer's Disease
6.3 Breast Cancer
6.4 Huntington Disease
6.5 Muscular Dystrophy
6.6 Others
6.7 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL INSULIN LIKE GROWTH FACTOR I BY CONSUMER 2012-2017
7.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
7.2 Alzheimer's Disease
7.3 Breast Cancer
7.4 Huntington Disease
7.5 Muscular Dystrophy
7.6 Others
7.7 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Boehringer Ingelheim GmbH
8.1.1 Boehringer Ingelheim GmbH Company Details and Competitors
8.1.2 Boehringer Ingelheim GmbH Key Insulin Like Growth Factor I Models and Performance
8.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.2 Genervon Biopharmaceuticals LLC
8.2.1 Genervon Biopharmaceuticals LLC Company Details and Competitors
8.2.2 Genervon Biopharmaceuticals LLC Key Insulin Like Growth Factor I Models and Performance
8.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.3 MedImmune LLC
8.3.1 MedImmune LLC Company Details and Competitors
8.3.2 MedImmune LLC Key Insulin Like Growth Factor I Models and Performance
8.3.3 MedImmune LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.3.4 MedImmune LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.4 Regulaxis SAS
8.4.1 Regulaxis SAS Company Details and Competitors
8.4.2 Regulaxis SAS Key Insulin Like Growth Factor I Models and Performance
8.4.3 Regulaxis SAS Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.4.4 Regulaxis SAS Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
...
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Insulin Like Growth Factor I Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Insulin Like Growth Factor I Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL INSULIN LIKE GROWTH FACTOR I MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
10.5 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
10.6 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
10.7 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
10.8 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
CHAPTER ELEVEN UNITED STATES INSULIN LIKE GROWTH FACTOR I MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
11.5 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
11.6 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
11.7 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
11.8 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Global Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
1.2 Insulin Like Growth Factor I, by B-845 2012-2017
1.2.1 Global Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
1.2.2 Global Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
1.2.3 Global Insulin Like Growth Factor I Price by B-845 2012-2017
1.2.4
1.2.5
1.3 Insulin Like Growth Factor I, by igitumab 2012-2017
1.3.1 Global Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
1.3.2 Global Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
1.3.3 Global Insulin Like Growth Factor I Price by igitumab 2012-2017
1.3.4
1.3.5
1.4 Insulin Like Growth Factor I, by 6 2012-2017
1.4.1 Global Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
1.4.2 Global Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
1.4.3 Global Insulin Like Growth Factor I Price by 6 2012-2017
1.4.4
1.4.5
1.5 Insulin Like Growth Factor I, by 10.27 2012-2017
1.5.1 Global Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
1.5.2 Global Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
1.5.3 Global Insulin Like Growth Factor I Price by 10.27 2012-2017
1.5.4
1.5.5
1.6 Insulin Like Growth Factor I, by 30 2012-2017
1.6.1 Global Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
1.6.2 Global Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
1.6.3 Global Insulin Like Growth Factor I Price by 30 2012-2017
1.6.4
1.6.5
CHAPTER TWO UNITED STATES INSULIN LIKE GROWTH FACTOR I MARKET OVERVIEW
2.1 United States Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
2.2 Insulin Like Growth Factor I, by B-845 2012-2017
2.2.1 United States Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
2.2.2 United States Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
2.2.3 United States Insulin Like Growth Factor I Price by B-845 2012-2017
2.2.4
2.2.5
2.3 Insulin Like Growth Factor I, by igitumab 2012-2017
2.3.1 United States Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
2.3.2 United States Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
2.3.3 United States Insulin Like Growth Factor I Price by igitumab 2012-2017
2.3.4
2.3.5
2.4 Insulin Like Growth Factor I, by 6 2012-2017
2.4.1 United States Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
2.4.2 United States Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
2.4.3 United States Insulin Like Growth Factor I Price by 6 2012-2017
2.4.4
2.4.5
2.5 Insulin Like Growth Factor I, by 10.27 2012-2017
2.5.1 United States Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
2.5.2 United States Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
2.5.3 United States Insulin Like Growth Factor I Price by 10.27 2012-2017
2.5.4
2.5.5
2.6 Insulin Like Growth Factor I, by 30 2012-2017
2.6.1 United States Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
2.6.2 United States Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
2.6.3 United States Insulin Like Growth Factor I Price by 30 2012-2017
2.6.4
2.6.5
CHAPTER THREE INSULIN LIKE GROWTH FACTOR I BY REGIONS 2012-2017
3.1 Global Insulin Like Growth Factor I Sales Market Share by Regions 2012-2017
3.2 Global Insulin Like Growth Factor I Revenue Market Share by Regions 2012-2017
3.3 Global Insulin Like Growth Factor I Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL INSULIN LIKE GROWTH FACTOR I BY COMPANIES 2012-2017
4.1 Global Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
4.2 Global Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
4.3 Global Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
4.4 Global Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES INSULIN LIKE GROWTH FACTOR I BY COMPANIES 2012-2017
5.1 United States Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
5.2 United States Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
5.3 United States Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
5.4 United States Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL INSULIN LIKE GROWTH FACTOR I BY CONSUMER 2012-2017
6.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
6.2 Alzheimer's Disease
6.3 Breast Cancer
6.4 Huntington Disease
6.5 Muscular Dystrophy
6.6 Others
6.7 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL INSULIN LIKE GROWTH FACTOR I BY CONSUMER 2012-2017
7.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
7.2 Alzheimer's Disease
7.3 Breast Cancer
7.4 Huntington Disease
7.5 Muscular Dystrophy
7.6 Others
7.7 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Boehringer Ingelheim GmbH
8.1.1 Boehringer Ingelheim GmbH Company Details and Competitors
8.1.2 Boehringer Ingelheim GmbH Key Insulin Like Growth Factor I Models and Performance
8.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.2 Genervon Biopharmaceuticals LLC
8.2.1 Genervon Biopharmaceuticals LLC Company Details and Competitors
8.2.2 Genervon Biopharmaceuticals LLC Key Insulin Like Growth Factor I Models and Performance
8.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.3 MedImmune LLC
8.3.1 MedImmune LLC Company Details and Competitors
8.3.2 MedImmune LLC Key Insulin Like Growth Factor I Models and Performance
8.3.3 MedImmune LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.3.4 MedImmune LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
8.4 Regulaxis SAS
8.4.1 Regulaxis SAS Company Details and Competitors
8.4.2 Regulaxis SAS Key Insulin Like Growth Factor I Models and Performance
8.4.3 Regulaxis SAS Insulin Like Growth Factor I Business SWOT Analysis and Forecast
8.4.4 Regulaxis SAS Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
...
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Insulin Like Growth Factor I Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Insulin Like Growth Factor I Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL INSULIN LIKE GROWTH FACTOR I MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
10.5 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
10.6 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
10.7 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
10.8 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
CHAPTER ELEVEN UNITED STATES INSULIN LIKE GROWTH FACTOR I MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
11.5 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
11.6 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
11.7 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
11.8 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES
Table Global Insulin Like Growth Factor I Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate
Table Global Insulin Like Growth Factor I Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate
